The ESMO National Societies Committee focuses on public policy, ESMO initiatives which are of strategic importance in improving the outcomes of cancer patients, and in reinforcing the specialisation of Medical Oncology.
Structure
The Committee reports directly to the ESMO Executive Board and is composed of:
- the Chair, who is nominated by the ESMO Executive Board
- the officially recognised National Medical or Clinical Oncology Societies, that are invited to join by the ESMO Executive Board and are in turn represented by their appointed National Liaison.
Terms of Office
The Committee Chair serves a two-year term which is once renewable.
National Society mandates are reviewed by the ESMO Executive Board every four years and mandates are renewable. The official Liaison term is for two years and can be renewed for one subsequent term.
Main Tasks & Responsibilities
The aim of the Committee is to form a bridge between ESMO and the National Medical or Clinical Oncology Societies to strengthen the relationship and create an effective local policy network of national societies who are responsible for:
- Identifying common needs and key areas of collaboration
- Engaging and ensuring the proper involvement of the local oncology communities and health authorities to support ESMO strategic initiatives
- Advocating for ESMO on the national level
Chair
- Elizabeth Smyth, UK
Members - National Societies (2021-2023)
- Albania: Albanian Oncology Association - AOA
- Armenia: Armenian Association of Hematology and Oncology - AAHO
- Australia: Medical Oncology Group of Australia - MOGA
- Belgium: Belgian Society of Medical Oncology - BSMO
- Brazil: Brazilian Society of Clinical Oncology - SBOC
- Canada: Canadian Association of Medical Oncologists - CAMO
- China: Chinese Society of Clinical Oncology - CSCO
- Croatia: Croatian Society of Medical Oncology - HDIO
- Cyprus: Cyprus Oncology Society - OEK
- Czech Republic: Czech Society for Oncology - COS
- Denmark: Danish Society for Clinical Oncology - DSKO
- Estonia: Estonian Society for Medical Oncology - EOÜ
- Finland: Finnish Society for Oncology
- France: French Society of Medical Oncology - SoFOM
- Germany: German Society for Haematology and Medical Oncology - DGHO
- Greece: Hellenic Society of Medical Oncology - HeSMO
- India: Indian Society of Medical and Pediatric Oncology - ISMPO
- Indonesia: Indonesian Society of Hematology Medical Oncology - ISHMO
- Iran: Iranian Society of Medical Oncology and Hematology - ISMOH
- Ireland: Irish Society of Medical Oncology - ISMO
- Israel: Israeli Society for Clinical Oncology and Radiation Therapy - ISCORT
- Italy: Italian Association of Medical Oncology - AIOM
- Japan: Japanese Society of Medical Oncology - JSMO
- Republic of Korea: Korean Society of Medical Oncology - KSMO
- Latvia: Latvian Association of Medical Oncologists - LOKA
- Lithuania: Lithuanian Society for Medical Oncology - LiSMO
- Luxembourg: Luxembourg Society of Oncology - SLO
- Mexico: Mexican Society of Oncology - SMeO
- Myanmar: Myanmar Oncology Society
- Netherlands: Dutch Society for Medical Oncology - NVMO
- New Zealand: New Zealand Society for Oncology - NZSO
- Philippines: Philippine Society of Medical Oncology - PSMO
- Poland: Polish Society of Clinical Oncology - PTOK
- Portugal: Portuguese Society of Oncology - SPO
- Russian Federation: Russian Society of Clinical Oncology - RUSSCO
- Serbia: Serbian Society for Medical Oncology - UMOS
- Singapore: Singapore Society of Oncology - SSO
- Slovakia: Slovak Oncology Society - SOS
- Slovenia: Slovenian Society for Medical Oncology
- Spain: Spanish Society of Medical Oncology - SEOM
- Sweden: Swedish Society of Oncology - SOF
- Switzerland: Swiss Society of Medical Oncology - SSMO
- Taiwan: Taiwan Oncology Society - TOS
- Thailand: Thai Society of Clinical Oncology - TSCO
- Turkey: Turkish Society of Medical Oncology - TSMO
- Ukraine: Association of Oncohematologists of Ukraine
- United Kingdom: Association of Cancer Physicians - ACP